Swiss biotech developing an antibody-based therapy targeting amyloid-beta and tau simultaneously to slow Alzheimer's progression.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
-
Total raised
-
Valuation
-
Employees
-
Founded
Latest round
Grant - August 31, 2026
Grant - €160,000
Grant
August 31, 2026
Venture Kick
Team
HZ
Hui Zhang
Founder
Open roles
PANDA Therapeutics is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile